Identification of chemoresistance-associated miRNAs in hypopharyngeal squamous cell carcinoma
Author(s) -
Elif Pala,
Tuba Denkçeken
Publication year - 2020
Publication title -
medicine science | international medical journal
Language(s) - English
Resource type - Journals
ISSN - 2147-0634
DOI - 10.5455/medscience.2019.08.9158
Subject(s) - docetaxel , microrna , cisplatin , hypopharyngeal cancer , identification (biology) , head and neck squamous cell carcinoma , oncology , linear discriminant analysis , basal cell , computational biology , cancer research , medicine , gene , biology , cancer , chemotherapy , computer science , genetics , head and neck cancer , artificial intelligence , botany
This study aimed to determine candidate miRNAs that could help to evaluate whether patients with hypopharyngeal squamous cell carcinoma (HSCC) would benefit from docetaxel, cisplatin, and 5-fluorouracil (TPF) induction chemotherapy. We downloaded the expression profiles of HSCC patients from the Gene Expression Omnibus database. miRNA profiles were analyzed via Principal Components Analysis (PCA), followed by Linear Discriminant Analysis (LDA). The Database Annotation for Visualization and Integrated Discovery tool was utilized for enrichment analysis; STRING and Cytoscape were used for network construction. We detected that hsa-miR-15b-5p, hsa-miR-93-5p, and hsa-miR-130a-3p might act as crucial regulators in chemoresistance of HSCC, and they may play as prognosticators and therapeutic targets in the future.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom